Haleh Bakshandeh
Dermatology · Beverly Hills, CANPI 1770684219
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $59,200 of the $87,613 with a category attached, or 67.6%. Sun Pharmaceutical Industries Inc. accounts for 93.6% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2021 at $32,416 and has fallen 96.3% since, to $1,202 in 2025. Among dermatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 398 payments — averaging $220.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$82K
- Galderma Laboratories, L.p.$1K
- Pfizer$976
- AbbVie$655
- Sanofi$323
- Revance Therapeutics, Inc.$314
- plus $2K from 25 others
What the payments were for
- Consulting fees$19,80023%
- Speaking & faculty fees$59,20068%
- Travel & lodging$4000%
- Food & beverage$8,2139%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 128 | $81,968 |
| Galderma Laboratories, L.p. | 60 | $1,029 |
| Pfizer | 58 | $976 |
| AbbVie(2 entities) | 31 | $655 |
| Sanofi | 12 | $323 |
| Revance Therapeutics, Inc. | 5 | $314 |
| EPI Health, LLC | 9 | $260 |
| Mayne Pharma Commercial LLC | 14 | $247 |
| Botanix SB Inc | 4 | $196 |
| LEO Pharma Inc. | 11 | $192 |
| Incyte Corporation | 9 | $186 |
| Journey Medical Corporation | 7 | $182 |
| Almirall LLC | 8 | $164 |
| Johnson & Johnson | 6 | $135 |
| VYNE Pharmaceuticals Inc. | 8 | $134 |
| Regeneron Healthcare Solutions, Inc. | 3 | $94 |
| Organon | 3 | $59 |
| Lilly USA, LLC | 2 | $58 |
| Amgen | 2 | $56 |
| Mindera Corp | 1 | $53 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $52 |
| Aclaris Therapeutics, Inc. | 2 | $45 |
| Bristol Myers Squibb | 2 | $42 |
| Dermira, Inc. | 2 | $34 |
| Encore Dermatology Inc. | 2 | $27 |
| Mission Pharmacal Company | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Promius Pharma LLC | 1 | $24 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $21 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Myriad Genetic Laboratories, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABSORICA LD$55,185
- Winlevi$27,365
- ABSORICA$4,510
- SOFDRA$154
- DAXXIFY$116
- Sitavig$111
- Cloderm$111
- Minolira 105mg$111
- Minolira 135mg$111
- Rhofade$111
How this compares
$87,613 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 11 | $41,114 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Beverly Hills
- Paul WallaceBeverly Hills$388K
- Jacquiline HabashyBeverly Hills$143K
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.